US BANCORP \DE\ - GAMIDA CELL LTD ownership

GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 55 filers reported holding GAMIDA CELL LTD in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of GAMIDA CELL LTD
ValueSharesWeighting
Q3 2023$824
-46.6%
8000.0%0.00%
Q2 2023$1,544
-4.9%
800
-60.1%
0.00%
Q1 2023$1,623
-37.2%
2,0040.0%0.00%
Q4 2022$2,585
-13.8%
2,0040.0%0.00%
Q3 2022$3,000
-25.0%
2,0040.0%0.00%
Q2 2022$4,000
-50.0%
2,0040.0%0.00%
Q1 2022$8,000
+166.7%
2,004
+66.4%
0.00%
Q4 2021$3,000
-40.0%
1,2040.0%0.00%
Q3 2021$5,000
-37.5%
1,2040.0%0.00%
Q2 2021$8,000
-20.0%
1,2040.0%0.00%
Q1 2021$10,0000.0%1,2040.0%0.00%
Q4 2020$10,000
+100.0%
1,2040.0%0.00%
Q3 2020$5,0001,2040.00%
Other shareholders
GAMIDA CELL LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,318,207$26,844,0002.86%
Stonepine Capital Management, LLC 244,515$1,978,0001.07%
Healthcare Value Capital, LLC 50,000$405,0000.90%
Rock Springs Capital Management LP 2,100,300$16,991,0000.37%
Dorsey Wright & Associates 3,619$29,278,0000.34%
FIRST MIDWEST BANK TRUST DIVISION 302,487$2,447,0000.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 107,000$862,0000.23%
Guild Investment Management, Inc. 15,000$121,0000.13%
PREMIER ASSET MANAGEMENT LLC 86,464$699,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 973,575$7,876,0000.12%
View complete list of GAMIDA CELL LTD shareholders